Form 4 for FBIO Fortress Biotech, Inc.
Accepted 2024-09-25 00:00:00 ET · period of report 2024-09-23 · accession 0001415889-24-023957 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-25 | 2024-09-23 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $1.84 | +763.4K | 3.66M | +26% | +$1.40M |
| D | 2024-09-25 | 2024-09-23 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $0.13 | +763.4K | 763.4K | New | +$99.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.001 | 2024-09-23 | P | A | 763,359 | $1.84 | 3,657,264 | D | — | — | |
| 2 | Derivative | Warrants to Purchase Common Stock | 2024-09-23 | P | A | 763,359 | $0.13 | 763,359 | D | $1.84 · 2025-03-23 to 2030-03-23 | 763,359 Common Stock |